MTOR and neoplasm: Furthermore, the phosphatidyl-inositol 3-kinase/mammalian target of the rapamycin (PI3K/AKT/mTOR) pathway is involved in survival, cell growth, cancer progression, tumour radio- and chemoresistance, as well as invasion and migration [75].